TNF and rheumatoid arthritis: MNT50 against ancestral SARS-CoV-2 in participants with RA on costimulation inhibitors, JAK inhibitors, TNF inhibitors, other drug classes (steroids ± DMARDs), and controls (C, grey squares) at 2–6 weeks post dose 3 (a), and 3 months post dose 4 (b).